XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash flows from operating activities:    
Net income $ 13,557 $ 19,013
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation, amortization and accretion expense 39,118 40,194
Amortization of deferred financing costs 2,325 1,370
Credit loss expense 37 88
Deferred income tax benefit 582 (2,836)
Equity-based employee and director compensation expense 1,123 954
(Gain) loss on dispositions and lease terminations, net (4,933) 302
Changes in operating assets and liabilities, net of acquisitions (4,546) (4,426)
Net cash provided by operating activities 47,263 54,659
Cash flows from investing activities:    
Principal payments received on notes receivable 107 66
Proceeds from sale of assets 4,533 3,793
Capital expenditures (11,328) (16,403)
Cash paid in connection with acquisitions, net of cash acquired   (1,885)
Net cash used in investing activities (6,688) (14,429)
Cash flows from financing activities:    
Borrowings under revolving credit facilities 205,900 57,600
Repayments on revolving credit facilities (50,546) (61,620)
Borrowings under the Term Loan Facility   1,120
Repayments on the Term Loan Facility (158,980) (24,600)
Net proceeds from issuance of preferred membership interests   24,430
Payments of finance lease obligations (1,417) (1,337)
Payments of deferred financing costs (7,022) (6)
Distributions paid on distribution equivalent rights (111) (93)
Income tax distributions paid on preferred membership interests (119)  
Distributions paid on common units (39,843) (39,800)
Net cash used in financing activities (52,138) (44,306)
Net decrease in cash and cash equivalents (11,563) (4,076)
Cash and cash equivalents at beginning of period 16,054 7,648
Cash and cash equivalents at end of period $ 4,491 $ 3,572